ViraFungal Fighter

Alzheimer's Disease

Resveratrol, found in grape seeds, is the subject of several human clinical trials, among which the most advanced is a one-year dietary regimen in a Phase III study of elderly patients with Alzheimer's disease.

In November 2008, researchers at the Weill Medical College of Cornell University reported that dietary supplementation with resveratrol significantly reduced plaque formation in animal brains, a component of Alzheimer and similar diseases. In mice, oral resveratrol produced large reductions in brain plaque in the hypothalamus (-90%), striatum (-89%), and medial cortex (-48%) sections of the brain. In humans it is theorized that oral doses of resveratrol may reduce beta amyloid plaque associated with aging changes in the brain. Researchers theorize that one that plaque can be eliminated is the ability of resveratrol to chelate (remove) copper.

In laboratory testing, resveratrol was reported effective against neuron-cell dysfunction and cell death, and in theory could help against diseases such as Huntington's disease and Alzheimer's disease. However, this has not yet been tested in humans for any disease.

The natural sources for ViraFungal Fighter may be affected by seasonal conditions. Occasional flavor and aroma variations may result. This does not affect the quality or potency of VFF.

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
WARNING: Do not use if you are allergic to grape seed extract or grapefruit seed extract. If symptooms persist or worsen, see a doctor.